Sumant Kulkarni Score: 33
Analyst at
Canaccord Genuity
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+102.4%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
80%
12 W / 3 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
50%
5 W / 5 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 10 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 10 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
92%
12 W / 1 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
80%
12 W / 3 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jun 09, 2026 |
Zevra Therapeutics Inc
ZVRA
|
BUY |
$29.00
Est. +140%
|
$12.09 | $14.58 |
Pending
|
$13.98
+15.6%
|
| Apr 20, 2026 |
ATAI Life Sciences N.V.
ATAI
|
BUY |
$15.00
Est. +188%
|
$5.20 | $5.52 |
Pending
|
$5.19
-0.2%
|
| Apr 16, 2026 |
Definium Therapeutics, Inc.
DFTX
|
BUY |
$38.00
Est. +72%
|
$22.15 | $49.20 |
Target Met
|
$44.19
+99.5%
|
| Feb 18, 2026 |
Compass Pathways Plc - ADR
CMPS
|
BUY |
$20.00
Est. +162%
|
$7.63 | $15.40 |
Pending
|
$13.62
+78.5%
|
| Feb 13, 2025 |
Biogen Inc
BIIB
|
BUY |
$265.00
Est. +92%
|
$138.06 | $202.41 |
Miss
|
$216.12
+56.5%
|
| Sep 18, 2024 |
Zevra Therapeutics Inc
ZVRA
|
BUY |
$22.00
Est. +192%
|
$7.53 | $13.16 |
Miss
|
$13.98
+85.7%
|
| Aug 06, 2024 |
Sage Therapeutics Inc
SAGE
|
BUY |
$9.00
Est. +1%
|
$8.88 | $9.36 |
Target Met
|
$8.68
-2.3%
|
| Jun 13, 2024 |
Cara Therapeutics Inc
CARA
|
BUY |
$1.00
Est. +47%
|
$0.68 | $19.08 |
Target Met
|
$5.32
+682.4%
|
| May 02, 2024 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$164.00
Est. +15%
|
$143.03 | $157.98 |
Miss
|
$174.26
+21.8%
|
| Apr 30, 2024 |
Annovis Bio Inc
ANVS
|
BUY |
$26.00
Est. +257%
|
$7.28 | $17.88 |
Miss
|
$1.93
-73.5%
|
| Apr 23, 2024 |
Intra-Cellular Therapies Inc
ITCI
|
BUY |
$107.00
Est. +44%
|
$74.54 | $131.98 |
Target Met
|
$131.87
+76.9%
|
| Apr 08, 2024 |
CervoMed Inc
CRVO
|
BUY |
$65.00
Est. +969%
|
$6.08 | $20.63 |
Miss
|
$3.55
-41.6%
|
| May 02, 2022 |
Clene Inc
CLNN
|
BUY |
$10.00
Est. +241%
|
$2.93 | $102.60 |
Target Met
|
$6.10
+108.2%
|
| Feb 28, 2022 |
Biogen Inc
BIIB
|
BUY |
$285.00
Est. +35%
|
$211.01 | - | - |
$216.12
+2.4%
|
| Aug 06, 2021 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$108.00
Est. +21%
|
$89.57 | - | - |
$174.26
+94.6%
|
Zevra Therapeutics Inc
ZVRA
Jun 09, 2026
Signal & Target
BUY
$29.00
Start Price
$12.09
Best Price (1Y)
$14.58
Current Price
$13.98
Return
+15.6%
ATAI Life Sciences N.V.
ATAI
Apr 20, 2026
Signal & Target
BUY
$15.00
Start Price
$5.20
Best Price (1Y)
$5.52
Current Price
$5.19
Return
-0.2%
Definium Therapeutics, Inc.
DFTX
Apr 16, 2026
Signal & Target
BUY
$38.00
Start Price
$22.15
Best Price (1Y)
$49.20
Current Price
$44.19
Return
+99.5%
Compass Pathways Plc - ADR
CMPS
Feb 18, 2026
Signal & Target
BUY
$20.00
Start Price
$7.63
Best Price (1Y)
$15.40
Current Price
$13.62
Return
+78.5%
Biogen Inc
BIIB
Feb 13, 2025
Signal & Target
BUY
$265.00
Start Price
$138.06
Best Price (1Y)
$202.41
Current Price
$216.12
Return
+56.5%
Zevra Therapeutics Inc
ZVRA
Sep 18, 2024
Signal & Target
BUY
$22.00
Start Price
$7.53
Best Price (1Y)
$13.16
Current Price
$13.98
Return
+85.7%
Sage Therapeutics Inc
SAGE
Aug 06, 2024
Signal & Target
BUY
$9.00
Start Price
$8.88
Best Price (1Y)
$9.36
Current Price
$8.68
Return
-2.3%
Cara Therapeutics Inc
CARA
Jun 13, 2024
Signal & Target
BUY
$1.00
Start Price
$0.68
Best Price (1Y)
$19.08
Current Price
$5.32
Return
+682.4%
Neurocrine Biosciences, Inc.
NBIX
May 02, 2024
Signal & Target
BUY
$164.00
Start Price
$143.03
Best Price (1Y)
$157.98
Current Price
$174.26
Return
+21.8%
Annovis Bio Inc
ANVS
Apr 30, 2024
Signal & Target
BUY
$26.00
Start Price
$7.28
Best Price (1Y)
$17.88
Current Price
$1.93
Return
-73.5%
Intra-Cellular Therapies Inc
ITCI
Apr 23, 2024
Signal & Target
BUY
$107.00
Start Price
$74.54
Best Price (1Y)
$131.98
Current Price
$131.87
Return
+76.9%
CervoMed Inc
CRVO
Apr 08, 2024
Signal & Target
BUY
$65.00
Start Price
$6.08
Best Price (1Y)
$20.63
Current Price
$3.55
Return
-41.6%
Clene Inc
CLNN
May 02, 2022
Signal & Target
BUY
$10.00
Start Price
$2.93
Best Price (1Y)
$102.60
Current Price
$6.10
Return
+108.2%
Biogen Inc
BIIB
Feb 28, 2022
Signal & Target
BUY
$285.00
Start Price
$211.01
Best Price (1Y)
-
Current Price
$216.12
Return
+2.4%
Neurocrine Biosciences, Inc.
NBIX
Aug 06, 2021
Signal & Target
BUY
$108.00
Start Price
$89.57
Best Price (1Y)
-
Current Price
$174.26
Return
+94.6%